<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Introduction to Biostatistics</title>
    <meta charset="utf-8" />
    <meta name="author" content="Dr. [Your Name]" />
    <meta name="date" content="2025-10-23" />
    <script src="libs/header-attrs/header-attrs.js"></script>
    <link href="libs/remark-css/default.css" rel="stylesheet" />
    <link href="libs/remark-css/metropolis.css" rel="stylesheet" />
    <link href="libs/remark-css/metropolis-fonts.css" rel="stylesheet" />
    <script src="libs/kePrint/kePrint.js"></script>
    <link href="libs/lightable/lightable.css" rel="stylesheet" />
  </head>
  <body>
    <textarea id="source">
class: center, middle, inverse, title-slide

.title[
# Introduction to Biostatistics
]
.subtitle[
## From Theory to Practice in Public Health
]
.author[
### Dr. [Your Name]
]
.institute[
### Ministry of Health, Rwanda / [Your Institution]
]
.date[
### October 23, 2025
]

---




class: center, middle, inverse, title-slide

# Introduction to Biostatistics
### Data Science &amp; Public Health in Rwanda
### October 23, 2025

---

class: inverse, center, middle

# Part 1: Foundations of Biostatistics

---

## Learning Objectives

By the end of this lecture, you will be able to:

.pull-left[
**Knowledge:**
- Define *biostatistics* and understand its *historical evolution*
- Identify the *applications and scope* of biostatistics in public health
- Describe the *types and nature of data* used in health research

]

.pull-right[
**Skills:**
- Understand *data organization* and *basic study designs*
- Apply statistical thinking to *Rwanda's public health context*
- Interpret basic health statistics and indicators
]

---

## What is Biostatistics?

.pull-left[
### Definition
Application of *statistical methods* to:
- Biological sciences
- Medical research
- Public health practice
- Healthcare delivery

### Purpose
Transform raw health data into:
- Evidence-based decisions
- Policy recommendations
- Clinical guidelines
- Research insights
]

.pull-right[
### Key Questions Biostatistics Answers:
1. How common is disease X in Rwanda?
2. Is treatment A better than treatment B?
3. What factors increase disease risk?
4. Are our interventions working?
5. How can we predict future trends?

&gt; "In God we trust, all others must bring data."
&gt;
&gt; — W. Edwards Deming
]

---

## Historical Evolution of Biostatistics

### Key Milestones

.pull-left[
**Early Period (1600s-1800s):**
- 1662: John Graunt's demographic analysis
- 1854: John Snow's cholera investigation
- 1863: Florence Nightingale's statistical charts

**Modern Era (1900s):**
- 1946: First randomized clinical trial
- 1948: Framingham Heart Study begins
- 1970: Computer-based statistics
]

.pull-right[
**Digital Age (2000s+):**
- Evidence-based medicine standard
- Big data and AI in healthcare
- Real-time health monitoring
- Mobile health and IoT devices
- Precision medicine and genomics
]

---

## Timeline of Biostatistics Evolution

&lt;img src="introduction_to_biostatistics_files/figure-html/timeline-1.png" width="95%" style="display: block; margin: auto;" /&gt;

---

## Historical Pioneers

.pull-left[
### John Graunt (1620-1674)
- First to analyze mortality data systematically
- Created life tables
- Founding father of demography

### Florence Nightingale (1820-1910)
- Used statistics to improve hospital conditions
- Created "coxcomb" diagrams
- Showed sanitation saves lives
]

.pull-right[
### John Snow (1813-1858)
- Father of epidemiology
- Mapped cholera outbreak in London
- Proved waterborne disease transmission

### Austin Bradford Hill (1897-1991)
- Designed first randomized clinical trial
- Established causation criteria
- Linked smoking to lung cancer
]

---

## Biostatistics in Rwanda's Context

&lt;table class="table table-striped table-hover table-condensed" style="font-size: 11px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;How Biostatistics Drives Rwanda's Health Success&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Health Area &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Achievement &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Role of Biostatistics &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Maternal Health &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; MMR reduced from 1,071 (2000) to 105 (2023) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; HMIS tracking, DHS surveys, facility data &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Child Mortality &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; U5MR dropped from 196 to 36 per 1,000 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Vital registration, demographic surveillance &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Malaria &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 60% reduction in malaria cases (2005-2020) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Surveillance systems, GIS mapping &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; HIV/AIDS &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; HIV prevalence stable at 3%, 90-90-90 achieved &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; RITA surveys, viral load monitoring &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Health Coverage &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 91% health insurance coverage &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; CBHI data analysis, equity assessments &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

class: inverse, center, middle

# Part 2: Applications of Biostatistics

---

## Core Application Areas

.pull-left[
### 1. Epidemiology
- Disease surveillance
- Outbreak investigation
- Risk factor identification
- Disease burden estimation

### 2. Clinical Research
- Clinical trials design
- Treatment effectiveness
- Diagnostic test accuracy
- Patient outcomes research
]

.pull-right[
### 3. Public Health Practice
- Program monitoring &amp; evaluation
- Health systems strengthening
- Policy development
- Resource allocation

### 4. Health Informatics
- HMIS dashboards
- Predictive analytics
- Quality improvement
- Real-time decision support
]

---

## Example: COVID-19 Response in Rwanda

&lt;img src="introduction_to_biostatistics_files/figure-html/covid-example-1.png" width="85%" style="display: block; margin: auto;" /&gt;

**Biostatistical methods used:** Time series analysis, testing positivity rates, vaccine effectiveness studies, transmission modeling

---

## Biostatistics in Clinical Trials

### Example: Malaria Vaccine Trial in Rwanda

.pull-left[
**Study Design:**
- Randomized controlled trial
- 2 groups: Vaccine vs. Placebo
- Sample size: 10,000 children
- Follow-up: 2 years

**Primary Outcome:**
- Clinical malaria incidence

**Statistical Methods:**
- Survival analysis
- Intention-to-treat analysis
- Subgroup analyses
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/trial-example-1.png" width="85%" style="display: block; margin: auto;" /&gt;

**Vaccine Efficacy = (1 - RR) × 100%**
]

---

class: inverse, center, middle

# Part 3: Types and Nature of Data

---

## Classification of Data Types

&lt;img src="introduction_to_biostatistics_files/figure-html/data-types-diagram-1.png" width="90%" style="display: block; margin: auto;" /&gt;

---

## Detailed Data Type Examples

&lt;table class="table table-striped table-hover" style="font-size: 10px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Comprehensive Guide to Data Types in Biostatistics&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Type &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Category &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Health Example &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Properties &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Statistical Methods &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(250, 219, 216, 255) !important;"&gt; Nominal &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; Categorical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; Blood type (A, B, AB, O) &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; No order, categories &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; Frequency, mode, chi-square &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(250, 219, 216, 255) !important;"&gt; Nominal &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; Categorical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; Sex (Male, Female) &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; Binary classification &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(250, 219, 216, 255) !important;"&gt; Proportion, odds ratio &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(214, 234, 248, 255) !important;"&gt; Ordinal &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Categorical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Cancer stage (I, II, III, IV) &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Ordered, unequal intervals &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Median, percentiles, rank tests &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(214, 234, 248, 255) !important;"&gt; Ordinal &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Categorical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Pain level (None, Mild, Moderate, Severe) &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Ranked severity &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(214, 234, 248, 255) !important;"&gt; Spearman correlation &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(213, 244, 230, 255) !important;"&gt; Discrete &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Numerical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Number of children &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Countable, whole numbers &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Mean, Poisson regression &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(213, 244, 230, 255) !important;"&gt; Discrete &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Numerical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Hospital admissions per year &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Count data &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(213, 244, 230, 255) !important;"&gt; Count models &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(253, 234, 168, 255) !important;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Numerical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Body weight (kg) &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Measurable, infinite precision &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Mean, SD, t-test, ANOVA &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2cm; font-weight: bold;background-color: rgba(253, 234, 168, 255) !important;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Numerical &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Blood glucose level (mg/dL) &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Lab values, decimals &lt;/td&gt;
   &lt;td style="text-align:left;background-color: rgba(253, 234, 168, 255) !important;"&gt; Correlation, regression &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

## Measurement Scales in Detail

.pull-left[
### Nominal Scale
- **Definition:** Categories without order
- **Examples:** Blood type, district names
- **Operations:** Count, mode

### Ordinal Scale
- **Definition:** Ordered categories
- **Examples:** Educational level, disease severity
- **Operations:** Median, percentiles
]

.pull-right[
### Interval Scale
- **Definition:** Equal intervals, no true zero
- **Examples:** Temperature (°C), dates, IQ scores
- **Operations:** Mean, SD (limited)

### Ratio Scale
- **Definition:** Equal intervals + true zero
- **Examples:** Weight, height, age, blood pressure
- **Operations:** All mathematical operations
]

---

## Data Sources in Public Health

&lt;table class="table table-striped table-hover table-condensed" style="font-size: 10px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Major Health Data Sources in Rwanda&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Data Source &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Type &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Frequency &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Key Data &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Strengths &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; HMIS &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Secondary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Service delivery, disease reports &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Real-time, comprehensive &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; DHS &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Primary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Every 5 years &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Fertility, mortality, nutrition &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Nationally representative &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; RBC Surveillance &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Secondary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Malaria, TB, HIV, COVID-19 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Disease-specific, timely &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Vital Registration &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Secondary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Births, deaths, marriages &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Legal documentation &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; CBHI &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Secondary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Enrollment, utilization &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Financial data, equity &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Laboratory Systems &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Secondary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Test results, diagnosis &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Accurate diagnosis &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; EMR &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Secondary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Continuous &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Patient history, treatments &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Individual-level data &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Special Surveys &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Primary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Periodic &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Risk factors, seroprevalence &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Specific research questions &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

class: inverse, center, middle

# Part 4: Data Organization &amp; Visualization

---

## Principles of Data Organization

.pull-left[
### Tidy Data Principles
1. Each variable = one column
2. Each observation = one row
3. Each type of observational unit = one table

### Example: Patient Data

| Patient_ID | Age | Sex | Weight | BP |
|------------|-----|-----|--------|-----|
| 001 | 35 | F | 62 | 120 |
| 002 | 42 | M | 78 | 135 |
| 003 | 28 | F | 55 | 115 |

✅ **This is tidy data!**
]

.pull-right[
### Common Data Issues

❌ **Multiple variables in one column**
```
Patient_001: Age_35_Sex_F
```

❌ **Variables in rows instead of columns**
```
Patient_001, Age, 35
Patient_001, Sex, F
```

### Data Cleaning Steps
1. Handle missing values
2. Remove duplicates
3. Standardize formats
4. Validate ranges
5. Document transformations
]

---

## Frequency Distributions

### Example: Age Distribution of Clinic Patients

.pull-left[
**Definition:**
- Shows how often each value occurs in a dataset
- Foundation for understanding data patterns

**Key Components:**
- Categories or intervals (Age Groups)
- Counts (Frequency)
- Proportions (Percentage)

**Uses in Biostatistics:**
- Describe population characteristics
- Identify patterns and trends
- Support hypothesis generation
]

.pull-right[
&lt;table class="table table-striped table-hover" style="font-size: 13px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Age Distribution (N=2,000)&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Age Group &lt;/th&gt;
   &lt;th style="text-align:right;"&gt; n &lt;/th&gt;
   &lt;th style="text-align:right;"&gt; % &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; 0-5 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 245 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 12.3 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; 6-17 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 312 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 15.6 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; 18-35 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 589 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 29.5 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; 36-50 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 428 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 21.4 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; 51-65 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 267 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 13.4 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; 65+ &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 159 &lt;/td&gt;
   &lt;td style="text-align:right;"&gt; 8.0 &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
]

---

## Visualization: Bar Charts

.pull-left[

``` r
# Create bar chart
ggplot(age_data,
       aes(x = Age_Group,
           y = Frequency,
           fill = Age_Group)) +
  geom_bar(stat = "identity") +
  geom_text(aes(label = Frequency),
            vjust = -0.5) +
  theme_minimal()
```

**When to use:**
- Compare categories
- Show frequencies
- Display counts
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/bar-chart-plot-1.png" width="85%" style="display: block; margin: auto;" /&gt;
]

---

## Visualization: Pie Charts

.pull-left[

``` r
# Disease distribution
disease_data &lt;- data.frame(
  Disease = c("Malaria",
              "Respiratory",
              "Diarrhea",
              "Skin",
              "Injuries",
              "Other"),
  Cases = c(320, 280, 195,
            145, 110, 250)
)

ggplot(disease_data,
       aes(x = "", y = Cases,
           fill = Disease)) +
  geom_bar(stat = "identity",
           width = 1) +
  coord_polar("y", start = 0)
```
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/pie-chart-plot-1.png" width="85%" style="display: block; margin: auto;" /&gt;
]

---

## Visualization: Histograms

.pull-left[

``` r
# Generate BMI data
set.seed(789)
bmi_data &lt;- data.frame(
  BMI = rnorm(500,
              mean = 24,
              sd = 4)
)

ggplot(bmi_data, aes(x = BMI)) +
  geom_histogram(bins = 30,
                 fill = "#3498db") +
  geom_density() +
  geom_vline(
    aes(xintercept = mean(BMI)),
    linetype = "dashed") +
  theme_minimal()
```
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/histogram-plot-1.png" width="85%" style="display: block; margin: auto;" /&gt;
]

---

## Time Series Visualization

.pull-left[

``` r
# MMR trend data
mmr_data &lt;- data.frame(
  Year = c(2000, 2005, 2010,
           2015, 2020, 2023),
  MMR = c(1071, 750, 476,
          290, 203, 105)
)

ggplot(mmr_data,
       aes(x = Year, y = MMR)) +
  geom_line() +
  geom_point() +
  geom_text(aes(label = MMR),
            vjust = -1) +
  theme_minimal()
```
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/time-series-plot-1.png" width="85%" style="display: block; margin: auto;" /&gt;
]

---

class: inverse, center, middle

# Part 5: Study Designs in Biostatistics

---

## Overview of Study Designs

&lt;img src="introduction_to_biostatistics_files/figure-html/study-designs-1.png" width="95%" style="display: block; margin: auto;" /&gt;

---

## Comparison of Study Designs

&lt;table class="table table-striped table-hover" style="font-size: 10px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Comparison of Major Study Designs&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Study Design &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Evidence &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Timeline &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Cost &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Best Used For &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Rwanda Example &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Cross-Sectional &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Low &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Point in time &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Low &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Prevalence, associations &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; DHS malaria prevalence &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Case-Control &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Moderate &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Retrospective &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Moderate &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Risk factors for rare diseases &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Cervical cancer risk factors &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Cohort Study &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; High &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Prospective &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; High &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Incidence, causation &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; CVD cohort study &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; RCT &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Very High &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Prospective &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Very High &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Treatment efficacy &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Malaria vaccine trial &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Systematic Review &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Highest &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Synthesis &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Moderate &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Evidence synthesis &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Meta-analysis of HIV interventions &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

## Case Study: Cross-Sectional Design

### Example: Nutrition Survey in Rwanda

.pull-left[
**Study Question:**
What is the prevalence of stunting among children under 5 in Rwanda?

**Design:**
- Single point in time
- Representative sample
- Measure height-for-age
- Classify: stunted vs. not stunted

**Sample Size:** 3,000 children

**Biostatistical Methods:**
- Descriptive statistics
- Prevalence estimation
- 95% confidence intervals
- Stratification by province
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/cross-sectional-example-1.png" width="85%" style="display: block; margin: auto;" /&gt;
]

---

## Case Study: Cohort Design

### Example: Community Health Worker Impact Study

&lt;img src="introduction_to_biostatistics_files/figure-html/cohort-example-1.png" width="85%" style="display: block; margin: auto;" /&gt;

**Hazard Ratio:** HR = 0.53 (95% CI: 0.41-0.68), p &lt; 0.001

**Interpretation:** Communities with CHWs have 47% lower child mortality

---

class: inverse, center, middle

# Part 6: Practical Applications &amp; Tools

---

## Essential Statistical Software

.pull-left[
### R &amp; RStudio
- Free, powerful, reproducible
- Used by: RBC, universities

### SPSS
- User-friendly interface
- Used in: Health facilities

### Stata
- Good for epidemiology
- Used by: Research institutions
]

.pull-right[
### Excel
- Accessible, familiar
- Widespread in Rwanda

### DHIS2
- Built for health data
- National HMIS standard

### Python
- Versatile, modern
- Emerging in health sector
]

---

## R Code Example: Basic Analysis


``` r
# Load sample data: Malaria test results from 5 districts
malaria_data &lt;- data.frame(
  District = c("Gasabo", "Kicukiro", "Nyarugenge", "Bugesera", "Rwamagana"),
  Tests_Conducted = c(1200, 950, 1100, 1450, 1300),
  Positive_Cases = c(145, 98, 132, 289, 234)
)

# Calculate positivity rate
malaria_data &lt;- malaria_data %&gt;%
  mutate(Positivity_Rate = (Positive_Cases / Tests_Conducted) * 100)

# Summary statistics
summary_stats &lt;- malaria_data %&gt;%
  summarise(
    Mean_Positivity = mean(Positivity_Rate),
    SD_Positivity = sd(Positivity_Rate),
    Min_Positivity = min(Positivity_Rate),
    Max_Positivity = max(Positivity_Rate)
  )

print(summary_stats)
```

```
##   Mean_Positivity SD_Positivity Min_Positivity Max_Positivity
## 1        14.46603      4.223099       10.31579       19.93103
```

---

## Visualization of Results

.pull-left[

``` r
# Create visualization
ggplot(malaria_data,
       aes(x = reorder(District,
                      -Positivity_Rate),
           y = Positivity_Rate,
           fill = Positivity_Rate)) +
  geom_col() +
  geom_text(
    aes(label = paste0(
      round(Positivity_Rate, 1),
      "%")),
    vjust = -0.5) +
  theme_minimal()
```
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/r-viz-plot-1.png" width="85%" style="display: block; margin: auto;" /&gt;
]

---

## Statistical Inference Example


``` r
# Hypothesis test: Are positivity rates different between urban and rural?
urban_rural_data &lt;- data.frame(
  Setting = c(rep("Urban", 3), rep("Rural", 2)),
  Positivity = c(12.1, 10.3, 12.0, 19.9, 18.0)
)

# Perform t-test
t_test_result &lt;- t.test(Positivity ~ Setting, data = urban_rural_data)

# Display results
cat("T-Test Results:\n")
```

```
## T-Test Results:
```

``` r
cat("Mean Urban:", round(t_test_result$estimate[2], 2), "%\n")
```

```
## Mean Urban: 11.47 %
```

``` r
cat("Mean Rural:", round(t_test_result$estimate[1], 2), "%\n")
```

```
## Mean Rural: 18.95 %
```

``` r
cat("P-value:", round(t_test_result$p.value, 4), "\n")
```

```
## P-value: 0.029
```

``` r
cat("95% CI:", round(t_test_result$conf.int[1], 2), "to",
    round(t_test_result$conf.int[2], 2), "\n")
```

```
## 95% CI: 2.04 to 12.92
```

``` r
if(t_test_result$p.value &lt; 0.05) {
  cat("\nConclusion: Significant difference exists (p &lt; 0.05)")
} else {
  cat("\nConclusion: No significant difference found (p ≥ 0.05)")
}
```

```
## 
## Conclusion: Significant difference exists (p &lt; 0.05)
```

---

## Key Health Indicators in Rwanda

&lt;table class="table table-striped table-hover" style="font-size: 10px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Rwanda's Key Health Indicators and Targets&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Health Indicator &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; 2020 Value &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; 2024 Target &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Status &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Maternal Mortality Ratio &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 203 per 100,000 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 150 per 100,000 &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(46, 204, 113, 255) !important;"&gt; On track &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Under-5 Mortality Rate &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 36 per 1,000 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 25 per 1,000 &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(231, 76, 60, 255) !important;"&gt; Needs acceleration &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Infant Mortality Rate &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 29 per 1,000 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 20 per 1,000 &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(46, 204, 113, 255) !important;"&gt; On track &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Neonatal Mortality Rate &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 19 per 1,000 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 12 per 1,000 &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(231, 76, 60, 255) !important;"&gt; Needs acceleration &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Total Fertility Rate &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 3.9 children &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 3.5 children &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(46, 204, 113, 255) !important;"&gt; On track &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Contraceptive Prevalence &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 64% &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 70% &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(46, 204, 113, 255) !important;"&gt; On track &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Antenatal Care (4+ visits) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 56% &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 80% &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(231, 76, 60, 255) !important;"&gt; Needs acceleration &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Institutional Delivery &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 94% &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 98% &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(46, 204, 113, 255) !important;"&gt; On track &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; Stunting (&amp;lt;5 years) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 33% &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 19% &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(231, 76, 60, 255) !important;"&gt; Needs acceleration &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 5cm; font-weight: bold;"&gt; HIV Prevalence (15-49) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; 3.0% &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; &amp;lt;2.5% &lt;/td&gt;
   &lt;td style="text-align:left;color: white !important;background-color: rgba(46, 204, 113, 255) !important;"&gt; On track &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

class: inverse, center, middle

# Part 7: Ethical Considerations &amp; Data Quality

---

## Ethics in Biostatistics

.pull-left[
### Core Principles

**1. Respect for Persons**
- Informed consent
- Confidentiality
- Privacy protection

**2. Beneficence**
- Maximize benefits
- Minimize risks
- Ensure scientific validity

**3. Justice**
- Fair participant selection
- Equitable distribution of benefits
- Access to research results
]

.pull-right[
### Practical Implications

**Data Collection:**
- Obtain ethical approval
- Secure consent forms
- Protect participant identity

**Data Analysis:**
- Honest reporting
- No data manipulation
- Transparent methods

**Data Sharing:**
- De-identification
- Secure storage
- Limited access

**Rwanda Context:**
- National Ethics Committee approval
- Data protection law compliance
]

---

## Data Quality Framework

&lt;img src="introduction_to_biostatistics_files/figure-html/data-quality-1.png" width="88%" style="display: block; margin: auto;" /&gt;

---

## Common Data Quality Issues

&lt;table class="table table-striped table-hover" style="font-size: 9px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Common Data Quality Issues and Solutions&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Issue &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Description &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Detection &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Solution &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Example &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2.5cm; font-weight: bold;"&gt; Missing Values &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Incomplete records, blank fields &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Count missing, % complete &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Imputation, deletion, sensitivity &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Birth weight not recorded &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2.5cm; font-weight: bold;"&gt; Outliers &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Extreme values beyond plausible range &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Box plots, Z-scores, IQR &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Verify, cap/truncate, transform &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Age recorded as 150 years &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2.5cm; font-weight: bold;"&gt; Duplicates &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Same patient entered multiple times &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Unique ID checks, fuzzy matching &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Remove duplicates, merge records &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Same patient registered twice &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2.5cm; font-weight: bold;"&gt; Inconsistent Formats &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Different date/naming conventions &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Regular expressions, validation &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Standardize using dictionary &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Date: 01/12/2023 vs 2023-12-01 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2.5cm; font-weight: bold;"&gt; Invalid Entries &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Values outside permitted range &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Range checks, logical rules &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Correction, deletion, follow-up &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Sex coded as '3' &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 2.5cm; font-weight: bold;"&gt; Temporal Issues &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Follow-up date before baseline &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Date sequence validation &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Re-check source, correct entry &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Death date before admission &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

class: inverse, center, middle

# Part 8: Real-World Case Studies

---

## Case Study 1: Malaria Elimination Strategy

### Rwanda's Goal: Eliminate malaria by 2030

.pull-left[
**Data Sources:**
- HMIS weekly surveillance
- Household surveys
- Meteorological data

**Statistical Methods:**
- Time series analysis
- Spatial mapping (GIS)
- Interrupted time series
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/malaria-case-1.png" width="85%" style="display: block; margin: auto;" /&gt;

**Finding:** IRS reduced incidence by 50% (IRR: 0.50, 95% CI: 0.45-0.56)
]

---

## Case Study 2: COVID-19 Vaccine Effectiveness

### Rwanda Cohort Study (N=50,000), 2021-2023

&lt;img src="introduction_to_biostatistics_files/figure-html/covid-vaccine-1.png" width="88%" style="display: block; margin: auto;" /&gt;

**Design:** Prospective cohort | **Method:** Cox regression adjusted for age, comorbidities

---

## Case Study 3: Nutrition Intervention Impact

### Does community-based nutrition education reduce child stunting?

.pull-left[
**Design:**
- Cluster randomized trial
- 40 sectors (20 vs. 20)
- 2,400 children under 2
- 18-month follow-up

**Intervention:**
- Monthly growth monitoring
- Nutrition counseling
- Recipe demonstrations
]

.pull-right[
&lt;img src="introduction_to_biostatistics_files/figure-html/nutrition-rct-1.png" width="85%" style="display: block; margin: auto;" /&gt;

**Result:** Difference-in-differences = -10% (95% CI: -14 to -6%, p&lt;0.001)
]

---

class: inverse, center, middle

# Part 9: Career Paths &amp; Resources

---

## Career Opportunities in Biostatistics

.pull-left[
### Rwanda-Specific Opportunities

**Government:**
- Rwanda Biomedical Center
- Ministry of Health (M&amp;E units)
- National Institute of Statistics Rwanda

**Academia:**
- University of Rwanda (SPH)
- University of Global Health Equity
- Research institutions

**NGOs &amp; Partners:**
- Clinton Health Access Initiative
- Partners In Health
- Management Sciences for Health
]

.pull-right[
### Skills in Demand

**Technical:**
- Statistical software (R, SPSS, Stata)
- Data visualization
- GIS/spatial analysis
- Machine learning basics

**Domain Knowledge:**
- Epidemiology
- Public health systems
- Clinical research
- Health economics

**Soft Skills:**
- Communication
- Collaboration
- Critical thinking
- Report writing
]

---

## Learning Resources

&lt;table class="table table-striped table-hover" style="font-size: 11px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Recommended Learning Resources for Biostatistics&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Category &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Resource &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Author/Provider &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Books &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Biostatistics for the Biological and Health Sciences &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Triola et al. &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Books &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Essential Medical Statistics &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Kirkwood &amp;amp; Sterne &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Books &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Fundamentals of Biostatistics &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Bernard Rosner &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Books &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; The Art of Statistics &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; David Spiegelhalter &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Online Courses &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Coursera: Biostatistics &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Johns Hopkins &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Online Courses &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; EdX: Principles of Biostatistics &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Harvard &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Online Courses &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Khan Academy: Statistics and Probability &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Khan Academy &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; Online Courses &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; DataCamp: Statistics with R &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; DataCamp &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; R Resources &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; R for Data Science (free) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Hadley Wickham &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; R Resources &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; R Graphics Cookbook &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Winston Chang &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 3cm; font-weight: bold;"&gt; R Resources &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Posit Cloud (free online) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Posit &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

## Recommended Practice Exercises

&lt;table class="table table-striped table-hover" style="font-size: 10px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;8-Week Practice Schedule for Biostatistics Mastery&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:right;"&gt; Week &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Topic &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Hands-On Exercise &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Dataset &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 1 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Data Types &amp;amp; Organization &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Classify variables from Rwanda DHS &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; DHS 2020 &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 2 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Descriptive Statistics &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Calculate mean, median, SD &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; HMIS extract &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 3 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Data Visualization &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Create bar, histogram, time series &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Malaria surveillance &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 4 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Probability Basics &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Calculate disease probabilities &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; COVID-19 data &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 5 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Hypothesis Testing &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Perform t-test comparing groups &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Clinical trial data &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 6 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Study Designs &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Design a study for research question &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Literature review &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 7 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Regression Analysis &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Analyze BMI and blood pressure &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; NCD survey &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:right;width: 1.5cm; font-weight: bold;"&gt; 8 &lt;/td&gt;
   &lt;td style="text-align:left;width: 3.5cm; font-weight: bold;background-color: rgba(236, 240, 241, 255) !important;"&gt; Real-World Project &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Complete district health data analysis &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; District HMIS &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

## Key Takeaways

.pull-left[
### Core Concepts
1. Biostatistics transforms health data into evidence
2. Proper study design is foundational
3. Data quality determines analysis validity
4. Visualization enhances understanding
5. Ethics must guide all research

### Rwanda Context
- HMIS is backbone of health data
- DHS provides population insights
- Digital health is expanding
- Evidence drives policy decisions
]

.pull-right[
### Next Steps
**As a Student:**
- Practice with real datasets
- Learn statistical software
- Read health research papers
- Join biostatistics communities
- Apply concepts to local problems

**Remember:**
&gt; "Statistics is the grammar of science."
&gt;
&gt; — Karl Pearson

&gt; "Without data, you're just another person with an opinion."
&gt;
&gt; — W. Edwards Deming
]

---

## Summary: The Biostatistics Workflow

&lt;img src="introduction_to_biostatistics_files/figure-html/workflow-1.png" width="95%" style="display: block; margin: auto;" /&gt;

---

## References &amp; Further Reading

### Key Publications
1. Rwanda Ministry of Health. (2020). *Rwanda Demographic and Health Survey 2019-20*.
2. Rwanda Biomedical Center. (2023). *Health Management Information System Annual Report*.
3. Farmer, P. E., et al. (2013). "Reduced premature mortality in Rwanda: lessons from success." *BMJ*, 346.
4. Binagwaho, A., et al. (2014). "Rwanda 20 years on: investing in life." *The Lancet*, 384(9940).

### Statistical Methods
5. Kirkwood, B. R., &amp; Sterne, J. A. (2003). *Essential Medical Statistics*.
6. Altman, D. G. (1991). *Practical Statistics for Medical Research*.

### Online Resources
- Rwanda DHS: https://www.statistics.gov.rw/
- WHO Health Statistics: https://www.who.int/data/gho
- Gapminder: https://www.gapminder.org/

---

## Appendix: Statistical Formulas

&lt;table class="table table-striped table-hover" style="font-size: 12px; margin-left: auto; margin-right: auto;"&gt;
&lt;caption style="font-size: initial !important;"&gt;Commonly Used Statistical Formulas&lt;/caption&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Statistic &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Formula &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Use Case &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 4cm; font-weight: bold;"&gt; Mean &lt;/td&gt;
   &lt;td style="text-align:left;font-family: monospace;"&gt; x̄ = Σxᵢ / n &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; |Central tendency &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 4cm; font-weight: bold;"&gt; Standard Deviation &lt;/td&gt;
   &lt;td style="text-align:left;font-family: monospace;"&gt; SD = √[Σ(xᵢ - x̄)² / (n-1)] &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; |Variability measure &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 4cm; font-weight: bold;"&gt; Standard Error &lt;/td&gt;
   &lt;td style="text-align:left;font-family: monospace;"&gt; SE = SD / √n &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Precision of mean &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 4cm; font-weight: bold;"&gt; Relative Risk &lt;/td&gt;
   &lt;td style="text-align:left;font-family: monospace;"&gt; RR = P(Disease&amp;amp;#124;Exposed) / P(Disease&amp;amp;#124;Unexposed) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Risk comparison &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 4cm; font-weight: bold;"&gt; Odds Ratio &lt;/td&gt;
   &lt;td style="text-align:left;font-family: monospace;"&gt; OR = (a × d) / (b × c) &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Case-control studies &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;width: 4cm; font-weight: bold;"&gt; Confidence Interval &lt;/td&gt;
   &lt;td style="text-align:left;font-family: monospace;"&gt; CI₉₅% = x̄ ± 1.96 × SE &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; |Range of estimates &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---

## Appendix: Sample Size Calculations


``` r
# Sample size for prevalence estimation
# Formula: n = (Z^2 * p * (1-p)) / e^2

calculate_sample_size &lt;- function(prevalence, margin_of_error, confidence = 0.95) {
  z &lt;- qnorm((1 + confidence) / 2)
  n &lt;- (z^2 * prevalence * (1 - prevalence)) / (margin_of_error^2)
  return(ceiling(n))
}

# Example: Estimating malaria prevalence
# Expected: 15%, Margin: 3%, 95% confidence
n_required &lt;- calculate_sample_size(prevalence = 0.15, margin_of_error = 0.03)
cat("Required sample size:", n_required, "participants\n")
```

```
## Required sample size: 545 participants
```

``` r
# Adjust for design effect and non-response
design_effect &lt;- 1.5
response_rate &lt;- 0.85
n_adjusted &lt;- ceiling(n_required * design_effect / response_rate)
cat("Adjusted sample size:", n_adjusted, "participants")
```

```
## Adjusted sample size: 962 participants
```

---

class: center, middle, inverse

# Questions &amp; Discussion

### Contact Information
**Email:** [your.email@institution.rw]

**Office:** [Your Office Location]

**Office Hours:** [Your Office Hours]

### Course Materials
All slides, datasets, and code available at:

**[Your Course Website/GitHub Repository]**

---

class: center, middle

# Thank You!

### Remember:
*"The best time to learn biostatistics was yesterday.*

*The second best time is today."*

**Let's transform health data into better lives for all Rwandans!**
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false,
"slideNumberFormat": "%current% / %total%",
"ratio": "16:9"
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
// add `data-at-shortcutkeys` attribute to <body> to resolve conflicts with JAWS
// screen reader (see PR #262)
(function(d) {
  let res = {};
  d.querySelectorAll('.remark-help-content table tr').forEach(tr => {
    const t = tr.querySelector('td:nth-child(2)').innerText;
    tr.querySelectorAll('td:first-child .key').forEach(key => {
      const k = key.innerText;
      if (/^[a-z]$/.test(k)) res[k] = t;  // must be a single letter (key)
    });
  });
  d.body.setAttribute('data-at-shortcutkeys', JSON.stringify(res));
})(document);
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
